John Blankenhorn

John Blankenhorn

InvestorPlace Contributor

Expertise: Biochemistry, biotechnology and pharmaceutical research

John Blankenhorn has been a researcher since 2016 and has years of experience and publications on the topics of biochemistry, biotechnology, and pharmaceutical research. His main interests are the application of biology and biotechnology to our daily lives, as well as the use of Machine Learning and AI to speed up research and development in the life sciences. He currently works at Emory University studying the structural basis of Alzheimer’s Disease.

Recent Articles

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

By John Blankenhorn, InvestorPlace Contributor

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development

By John Blankenhorn, InvestorPlace Contributor

These pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better.

If You Can Only Buy One Battery Stock in December, It Better Be One of These 3 Names

By John Blankenhorn, InvestorPlace Contributor

These are three of the top battery stocks bringing products of the future to solve the problems of today. Consider picking them up now.

3 Flying Car Stocks That Could Be Multibaggers in the Making

By John Blankenhorn, InvestorPlace Contributor

Flying cars are set to be the wave of the future. Don't let this opportunity to invest in flying car stocks fly away from you.

7 Biotech Stocks to Get In Now Before Investors Catch On

By John Blankenhorn, InvestorPlace Contributor

Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.

Load More